• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经静脉膈神经刺激改善中枢性睡眠呼吸暂停的夜间低氧血症负担。

Improving Nocturnal Hypoxemic Burden with Transvenous Phrenic Nerve Stimulation for the Treatment of Central Sleep Apnea.

机构信息

Clinic for Thoracic and Cardiovascular Surgery, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, Bad Oeynhausen, Germany.

Ludgerus-Kliniken Münster, Clemenshospital, Münster, Germany.

出版信息

J Cardiovasc Transl Res. 2021 Apr;14(2):377-385. doi: 10.1007/s12265-020-10061-0. Epub 2020 Aug 12.

DOI:10.1007/s12265-020-10061-0
PMID:32789619
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8043931/
Abstract

Nocturnal hypoxemic burden is established as a robust prognostic metric of sleep-disordered breathing (SDB) to predict mortality and treating hypoxemic burden may improve prognosis. The aim of this study was to evaluate improvements in nocturnal hypoxemic burden using transvenous phrenic nerve stimulation (TPNS) to treat patients with central sleep apnea (CSA). The remedē System Pivotal Trial population was examined for nocturnal hypoxemic burden. The minutes of sleep with oxygen saturation < 90% significantly improved in Treatment compared with control (p < .001), with the median improving from 33 min at baseline to 14 min at 6 months. Statistically significant improvements were also observed for average oxygen saturation and lowest oxygen saturation. Hypoxemic burden has been demonstrated to be more predictive for mortality than apnea-hypopnea index (AHI) and should be considered a key metric for therapies used to treat CSA. Transvenous phrenic nerve stimulation is capable of delivering meaningful improvements in nocturnal hypoxemic burden. There is increasing interest in endpoints other than apnea-hypopnea index in sleep-disordered breathing. Nocturnal hypoxemia burden may be more predictive for mortality than apnea-hypopnea index in patients with poor cardiac function. Transvenous phrenic nerve stimulation is capable of improving nocturnal hypoxemic burden. Graphical Abstract.

摘要

夜间低氧血症负担被确立为睡眠呼吸障碍(SDB)的一个强大预后指标,用于预测死亡率,而治疗低氧血症负担可能改善预后。本研究旨在评估使用经静脉膈神经刺激(TPNS)治疗中枢性睡眠呼吸暂停(CSA)患者时夜间低氧血症负担的改善情况。对 remedē 系统关键试验人群进行了夜间低氧血症负担评估。与对照组相比,治疗组的睡眠中氧饱和度<90%的分钟数显著改善(p<.001),中位数从基线时的 33 分钟改善至 6 个月时的 14 分钟。平均氧饱和度和最低氧饱和度也观察到了统计学上的显著改善。已经证明,低氧血症负担比呼吸暂停低通气指数(AHI)更能预测死亡率,应被视为治疗 CSA 所使用疗法的关键指标。经静脉膈神经刺激能够显著改善夜间低氧血症负担。在睡眠呼吸障碍中,除了呼吸暂停低通气指数之外,其他终点也越来越受到关注。在心脏功能较差的患者中,夜间低氧血症负担可能比呼吸暂停低通气指数更能预测死亡率。经静脉膈神经刺激能够改善夜间低氧血症负担。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e406/8043931/69b5aa6d09f6/12265_2020_10061_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e406/8043931/b076504eccc4/12265_2020_10061_Figa_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e406/8043931/002e77f60a09/12265_2020_10061_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e406/8043931/77c942df9929/12265_2020_10061_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e406/8043931/b076504eccc4/12265_2020_10061_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e406/8043931/69b5aa6d09f6/12265_2020_10061_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e406/8043931/b076504eccc4/12265_2020_10061_Figa_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e406/8043931/002e77f60a09/12265_2020_10061_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e406/8043931/77c942df9929/12265_2020_10061_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e406/8043931/b076504eccc4/12265_2020_10061_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e406/8043931/69b5aa6d09f6/12265_2020_10061_Fig4_HTML.jpg

相似文献

1
Improving Nocturnal Hypoxemic Burden with Transvenous Phrenic Nerve Stimulation for the Treatment of Central Sleep Apnea.经静脉膈神经刺激改善中枢性睡眠呼吸暂停的夜间低氧血症负担。
J Cardiovasc Transl Res. 2021 Apr;14(2):377-385. doi: 10.1007/s12265-020-10061-0. Epub 2020 Aug 12.
2
Transvenous phrenic nerve stimulation for the treatment of central sleep apnea reduces episodic hypoxemic burden.经静脉膈神经刺激治疗中枢性睡眠呼吸暂停可减轻间歇性低氧血症负担。
Int J Cardiol. 2023 May 1;378:89-95. doi: 10.1016/j.ijcard.2023.02.041. Epub 2023 Feb 24.
3
Phrenic nerve stimulation for the treatment of central sleep apnea.膈神经刺激治疗中枢性睡眠呼吸暂停。
JACC Heart Fail. 2015 May;3(5):360-369. doi: 10.1016/j.jchf.2014.12.013. Epub 2015 Mar 11.
4
Transvenous phrenic nerve stimulation is associated with normalization of nocturnal heart rate perturbations in patients with central sleep apnea.经静脉膈神经刺激可使中枢性睡眠呼吸暂停患者的夜间心率紊乱正常化。
Sleep. 2023 Sep 8;46(9). doi: 10.1093/sleep/zsad166.
5
Transvenous phrenic nerve stimulation improves central sleep apnea, sleep quality, and quality of life regardless of prior positive airway pressure treatment.经静脉膈神经刺激可改善中枢性睡眠呼吸暂停,无论先前是否接受过正压通气治疗,均能改善睡眠质量和生活质量。
Sleep Breath. 2021 Dec;25(4):2053-2063. doi: 10.1007/s11325-021-02335-x. Epub 2021 Mar 20.
6
Long-term efficacy and safety of phrenic nerve stimulation for the treatment of central sleep apnea.膈肌神经刺激治疗中枢性睡眠呼吸暂停的长期疗效和安全性。
Sleep. 2019 Oct 21;42(11). doi: 10.1093/sleep/zsz158.
7
Transvenous phrenic nerve stimulation to treat idiopathic central sleep apnea.经静脉膈神经刺激治疗特发性中枢性睡眠呼吸暂停。
J Clin Sleep Med. 2020 Dec 15;16(12):2099-2107. doi: 10.5664/jcsm.8802.
8
How to implant a phrenic nerve stimulator for treatment of central sleep apnea?如何植入膈神经刺激器治疗中枢性睡眠呼吸暂停?
J Cardiovasc Electrophysiol. 2019 May;30(5):792-799. doi: 10.1111/jce.13898. Epub 2019 Mar 18.
9
Design of the remedē System Pivotal Trial: A Prospective, Randomized Study in the Use of Respiratory Rhythm Management to Treat Central Sleep Apnea.remedē 系统关键试验设计:使用呼吸节律管理治疗中枢性睡眠呼吸暂停的前瞻性随机研究。
J Card Fail. 2015 Nov;21(11):892-902. doi: 10.1016/j.cardfail.2015.08.344.
10
Transvenous stimulation of the phrenic nerve for the treatment of central sleep apnoea: 12 months' experience with the remedē System.经静脉刺激膈神经治疗中枢性睡眠呼吸暂停:remedē 系统 12 个月的经验。
Eur J Heart Fail. 2016 Nov;18(11):1386-1393. doi: 10.1002/ejhf.593. Epub 2016 Jul 4.

引用本文的文献

1
Revisiting Transvenous Phrenic Nerve Stimulation in Central Sleep Apnoea and Heart Failure: Emerging Innovations in Clinical Trials Analysis.重新审视经静脉膈神经刺激治疗中枢性睡眠呼吸暂停和心力衰竭:临床试验分析中的新进展
Card Fail Rev. 2025 Aug 20;11:e22. doi: 10.15420/cfr.2025.07. eCollection 2025.
2
Intermittent hypoxia index: a new indicator for assessing the degree of intermittent hypoxia in obstructive sleep apnea.间歇性低氧指数:一种评估阻塞性睡眠呼吸暂停中间歇性低氧程度的新指标。
Front Med (Lausanne). 2025 Apr 29;12:1400376. doi: 10.3389/fmed.2025.1400376. eCollection 2025.
3
Treating central sleep apnoea in heart failure: progressing one step at a time.

本文引用的文献

1
Sleep - the yet underappreciated player in cardiovascular diseases: A clinical review from the German Cardiac Society Working Group on Sleep Disordered Breathing.睡眠——心血管疾病中尚未得到充分重视的因素:德国心脏病学会睡眠呼吸障碍工作组的临床综述
Eur J Prev Cardiol. 2021 Apr 10;28(2):189-200. doi: 10.1177/2047487319879526.
2
Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data.适应性伺服通气疗法不能改善收缩期心力衰竭合并中枢性呼吸暂停睡眠患者的交感-迷走神经平衡:初步数据。
Int J Cardiol. 2020 Sep 15;315:59-66. doi: 10.1016/j.ijcard.2020.03.078. Epub 2020 Apr 2.
3
治疗心力衰竭中的中枢性睡眠呼吸暂停:一步一个脚印地前进。
Eur Respir Rev. 2024 Oct 30;33(174). doi: 10.1183/16000617.0218-2024. Print 2024 Oct.
4
Central sleep apnoea: not just one phenotype.中枢性睡眠呼吸暂停:不仅仅是一种表型。
Eur Respir Rev. 2024 Mar 27;33(171). doi: 10.1183/16000617.0141-2023. Print 2024 Jan 31.
5
Predictors of Nocturnal Hypoxemic Burden in Patients Undergoing Elective Coronary Artery Bypass Grafting Surgery.接受择期冠状动脉旁路移植手术患者夜间低氧血症负担的预测因素
Biomedicines. 2023 Sep 28;11(10):2665. doi: 10.3390/biomedicines11102665.
6
Hypoxaemic burden in heart failure patients receiving adaptive servo-ventilation.心力衰竭患者接受适应性伺服通气时的低氧血症负担。
ESC Heart Fail. 2023 Dec;10(6):3725-3728. doi: 10.1002/ehf2.14556. Epub 2023 Oct 4.
7
Association of hypoxic burden metrics with cardiovascular outcomes in heart failure and sleep-disordered breathing.缺氧负担指标与心力衰竭和睡眠呼吸障碍患者心血管结局的相关性研究。
ESC Heart Fail. 2023 Dec;10(6):3504-3514. doi: 10.1002/ehf2.14526. Epub 2023 Sep 19.
8
Self-reported symptoms of sleep-disordered breathing and risk of cardiovascular diseases: Observational and Mendelian randomization findings.自述的睡眠呼吸障碍症状与心血管疾病风险:观察性和孟德尔随机化研究结果。
J Sleep Res. 2022 Dec;31(6):e13681. doi: 10.1111/jsr.13681. Epub 2022 Jul 22.
9
Effects of sacubitril-valsartan on central and obstructive apneas in heart failure patients with reduced ejection fraction.沙库巴曲缬沙坦对射血分数降低的心力衰竭患者中枢性和阻塞性呼吸暂停的影响。
Sleep Breath. 2023 Mar;27(1):283-289. doi: 10.1007/s11325-022-02623-0. Epub 2022 Apr 29.
10
Transvenous Phrenic Nerve Stimulation for Central Sleep Apnea: Clinical and Billing Review.经静脉膈神经刺激治疗中枢性睡眠呼吸暂停:临床和计费审查。
Chest. 2022 May;161(5):1330-1337. doi: 10.1016/j.chest.2021.11.012. Epub 2021 Nov 19.
Long-term efficacy and safety of phrenic nerve stimulation for the treatment of central sleep apnea.
膈肌神经刺激治疗中枢性睡眠呼吸暂停的长期疗效和安全性。
Sleep. 2019 Oct 21;42(11). doi: 10.1093/sleep/zsz158.
4
Sleep duration and architecture during ASV for central sleep apnoea in systolic heart failure.在收缩性心力衰竭中,使用自动同步呼吸机治疗中枢性睡眠呼吸暂停期间的睡眠持续时间和结构。
Respir Physiol Neurobiol. 2020 Jan;271:103286. doi: 10.1016/j.resp.2019.103286. Epub 2019 Sep 14.
5
Impact of Simulated Hyperventilation and Periodic Breathing on Sympatho-Vagal Balance and Hemodynamics in Patients with and without Heart Failure.模拟过度通气和周期性呼吸对心力衰竭患者和非心力衰竭患者的交感神经-迷走神经平衡和血液动力学的影响。
Respiration. 2019;98(6):482-494. doi: 10.1159/000502155. Epub 2019 Aug 28.
6
Interventional techniques to increase implantation success of transvenous phrenic nerve stimulation for central sleep apnea treatment.介入技术增加经静脉膈神经刺激治疗中枢性睡眠呼吸暂停的植入成功率。
Sleep Breath. 2020 Sep;24(3):905-912. doi: 10.1007/s11325-019-01917-0. Epub 2019 Aug 12.
7
APAP therapy does not improve impaired sleep quality and sympatho-vagal balance: a randomized trial in patients with obstructive sleep apnea and systolic heart failure.APAP 治疗并不能改善阻塞性睡眠呼吸暂停和收缩性心力衰竭患者的睡眠质量受损和自主神经平衡:一项随机试验。
Sleep Breath. 2020 Mar;24(1):211-219. doi: 10.1007/s11325-019-01868-6. Epub 2019 Jun 25.
8
Auto positive airway pressure therapy reduces pulmonary pressures in adults admitted for acute heart failure with pulmonary hypertension and obstructive sleep apnea. The ASAP-HF Pilot Trial.自动气道正压治疗可降低合并肺动脉高压和阻塞性睡眠呼吸暂停的急性心力衰竭成人患者的肺压。ASAP-HF 先导试验。
Sleep. 2019 Jul 8;42(7). doi: 10.1093/sleep/zsz100.
9
Composition of nocturnal hypoxaemic burden and its prognostic value for cardiovascular mortality in older community-dwelling men.夜间低氧血症负担的构成及其对老年社区男性心血管死亡率的预后价值。
Eur Heart J. 2020 Jan 21;41(4):533-541. doi: 10.1093/eurheartj/ehy838.
10
The hypoxic burden of sleep apnoea predicts cardiovascular disease-related mortality: the Osteoporotic Fractures in Men Study and the Sleep Heart Health Study.睡眠呼吸暂停的低氧负荷可预测心血管疾病相关死亡率:男性骨质疏松性骨折研究和睡眠心脏健康研究。
Eur Heart J. 2019 Apr 7;40(14):1149-1157. doi: 10.1093/eurheartj/ehy624.